Managed by the Polsky Center, the George Shultz Innovation Fund provides up to $250,000 in co-investment funding for early stage tech ventures coming out of University of Chicago, Argonne National Laboratory, Fermilab, and the Marine Biological Laboratory.

What makes a successful application?

The George Shultz Innovation Fund looks for projects that have a high chance of commercial viability and large potential for impact. Past successful applicants have shared the following characteristics:

  • Committed team with dedicated technology and business founders
  • Significant technical milestones have been achieved:
    • Drug: Lead candidate(s) identified (or nearly)
    • Device: Initial prototype completed
    • Software: MVP released to initial customers
  • The technology is demonstrably better/different than what is already available.
  • The value proposition of the technology has been validated with end customers
  • The work to be funded will likely lead to outside funding, customers, or other engagement.

Spring Deadline

February 12, 2024

Your information has been submitted. Thanks!